SCHEMBL1135461

SCHEMBL1135461

CCC(O)c1ccc(OC[C@@H](O)CO)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 1/20 0.51
▸ TSHR P16473 3/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ LMNA P02545 3/20 0.46
▸ POLB P06746 2/20 0.45
▸ MAPT P10636 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ CYP1A2 P05177 2/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ AGTR1 P30556 1/20 0.44
▸ KMT2A Q03164 2/20 0.42
▸ MAP4K4 O95819 1/20 0.41
▸ PRKCD Q05655 1/20 0.41
▸ MINK1 Q8N4C8 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ GLA P06280 1/20 0.41
▸ USP2 O75604 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ PTGS1 P23219 1/20 0.41
▸ SLC6A2 P23975 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17036996 0.85 ALDH1A1 (0.55) ARTSHRMAPK1LMNAPOLB
SCHEMBL6228324 0.83 AR (0.61) ARTSHRMAPK1LMNAPOLB
SCHEMBL15801265 0.82 KMT2A (0.59) ARTSHRMAPK1LMNAPOLB
SCHEMBL15801262 0.82 KMT2A (0.59) ARTSHRMAPK1LMNAPOLB
SCHEMBL8541521 0.82 KMT2A (0.59) ARTSHRMAPK1LMNAPOLB
SCHEMBL31213834 0.82 AR (0.53) ARTSHRMAPK1LMNAPOLB
SCHEMBL26326216 0.82 AR (0.53) ARTSHRMAPK1LMNAPOLB
SCHEMBL6055121 0.80 NQO1 (0.58) TSHRLMNAMAPTKMT2ASMN1; SMN2
SCHEMBL15677161 0.79 AR (0.54) ARTSHRMAPK1LMNAPOLB
SCHEMBL1496690 0.78 TSHR (0.62) ARTSHRMAPK1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2285785-A1 3,5-DIAMINO-6-CHLORO-PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS EPITHELIAL SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF ARWAY DISEASES Novartis AG (CH) 2011-02-23 — — EP disclosed
WO-2009138378-A1 3,5-DIAMINO-6-CHLORO-PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS EPITHELIAL SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF ARWAY DISEASES NOVARTIS AG (CH) 2009-11-19 — — WO disclosed
Send feedback